Trial Profile
Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2012
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Raltegravir (Primary)
- Indications HIV infections; Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- 26 Sep 2012 New trial record